Health Condition 1: - Health Condition 2: I220- Subsequent ST elevation (STEMI) myocardial infarction of anterior wall
Conditions
Interventions
None listed
Sponsors
Institute of cardiovascular diseases
Eligibility
Inclusion criteria
Inclusion criteria: Patients who will be undergoing PCI for chronic stable angina or acute coronary syndrome (ACS) â?? unstable angina (UA)/ non ST-elevation myocardial infarction (NSTEMI), with at least one of the following risk factors for CI-AKI. Age > 18 years Diabetic or hypertensive nephropathy eGFR Functionally single kidney Previous renal transplantation Haemoglobin Recent decompensated heart failure within one month Left ventricular ejection fraction Systolic blood pressure
Exclusion criteria
Exclusion criteria: Complex type C lesions Chronic total occlusion Planned double stent strategy for bifurcation lesion Lesions requiring rotational atherectomy Cardiogenic shock STEMI patients who will be undergoing Primary PCI Stent thrombosis
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Successful completion of PCI without contrast and absence of geographic miss, coronary artery perforation or coronary artery dissection and TIMI III flow in the final check angiogram. Timepoint: Successful completion of PCI without contrast and absence of geographic miss, coronary artery perforation or coronary artery dissection and TIMI III flow in the final check angiogram. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Composite of major adverse cardio cerebro vascular events at one month follow up namely death, myocardial infarction (MI), repeat revasculariisation and stroke. 2) Death at one month followup 3) MI at one month followup 4) Repeat revascularisation at one month followup 5) Stroke at one month followup 6) percent change in eGFR at one month followup 7) Need for renal replacement therapy (RRT) at one month followupTimepoint: 1)Composite of major adverse cardio cerebro vascular events at one month follow up namely death, myocardial infarction (MI), repeat revasculariisation and stroke. 2) Death at one month followup 3) MI at one month followup 4) Repeat revascularisation at one month followup 5) Stroke at one month followup 6) percent change in eGFR at one month followup 7) Need for renal replacement therapy (RRT) at one month followup | — |
Countries
India
Contacts
Public ContactDrAjit Mullasari
The Madras Medical Mission
Outcome results
None listed